Captrust Financial Advisors Merck & Co., Inc. Transaction History

Captrust Financial Advisors

$30.9 Billion
Q2 2024

A detailed history of Captrust Financial Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 1,067,825 shares of MRK stock, worth $105 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

1,067,825

Previous 1,048,886 1.81%

Holding current value

$105 Million

Previous $138 Million 4.48%

% of portfolio

0.43%

Previous 0.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $2.34 Million - $2.52 Million	18,939 Added 1.81%	1,067,825 $132 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $12.7 Million - $14.8 Million	-111,891 Reduced 9.64%	1,048,886 $138 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $2.72 Million - $2.96 Million	27,178 Added 2.4%	1,160,777 $127 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $10.2 Million - $11.3 Million	98,848 Added 9.55%	1,133,599 $117 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $5.98 Million - $6.52 Million	55,104 Added 5.62%	1,034,751 $119 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $8.68 Million - $9.68 Million	84,284 Added 9.41%	979,647 $104 Million
Q4 2022 Feb 15, 2023	BUY	$87.44 - $112.11 $3.52 Million - $4.52 Million	40,291 Added 4.71%	895,363 $99.3 Million
Q3 2022 Nov 16, 2022	BUY	$84.53 - $94.96 $11.3 Million - $12.7 Million	133,266 Added 18.46%	855,072 $73.6 Million
Q2 2022 Aug 23, 2022	SELL	$83.49 - $94.64 $2.64 Million - $3 Million	-31,657 Reduced 4.2%	721,806 $66.3 Million
Q2 2022 Aug 16, 2022	BUY	$83.49 - $94.64 $13.1 Million - $14.8 Million	156,627 Added 26.24%	753,463 $68.7 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $10.6 Million - $11.9 Million	143,892 Added 31.77%	596,836 $49.4 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $11 Million - $13.8 Million	152,635 Added 50.83%	452,944 $35 Million
Q3 2021 Nov 16, 2021	BUY	$71.68 - $78.83 $793,354 - $872,490	11,068 Added 3.83%	300,309 $22.8 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $27 Million - $29.9 Million	-383,971 Reduced 57.04%	289,241 $22.7 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $3.04 Million - $3.59 Million	44,217 Added 7.03%	673,212 $52.3 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $5.41 Million - $6 Million	75,325 Added 13.6%	628,995 $51.9 Million
Q3 2020 Nov 17, 2020	SELL	$73.18 - $82.95 $5.81 Million - $6.59 Million	-79,395 Reduced 12.54%	553,670 $45.5 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $4.27 Million - $4.86 Million	60,687 Added 10.6%	633,065 $49.8 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $678,395 - $940,288	10,707 Added 1.91%	572,378 $42.6 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $32.5 Million - $36.7 Million	418,993 Added 293.66%	561,671 $52 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $956,934 - $1.04 Million	-12,578 Reduced 8.1%	142,678 $12.1 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $822,435 - $960,803	11,776 Added 8.21%	155,256 $13.1 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $331,339 - $377,912	4,762 Added 3.43%	143,480 $12 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $6,328 - $7,343	-97 Reduced 0.07%	138,718 $10.7 Million
Q3 2018 Nov 15, 2018	BUY	$57.69 - $67.84 $2.68 Million - $3.15 Million	46,468 Added 50.32%	138,815 $9.91 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $738,102 - $867,194	14,521 Added 18.66%	92,347 $5.65 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $254,698 - $296,031	-4,998 Reduced 6.03%	77,826 $4.18 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $4.24 Million - $5.06 Million	82,105 Added 11419.33%	82,824 $4.7 Million
Q3 2017 Feb 16, 2018	BUY	$58.67 - $63.13 $42,183 - $45,390	719	719 $39,000

Others Institutions Holding MRK

# of Institutions

3,797

Shares Held

1.92B

Call Options Held

13.3M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $250B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Merck & Co., Inc. Transaction History